{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T05:20:36Z","timestamp":1783401636460,"version":"3.54.6"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,6,7]],"date-time":"2026-06-07T00:00:00Z","timestamp":1780790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,7]],"date-time":"2026-06-07T00:00:00Z","timestamp":1780790400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1007\/s10067-026-08198-5","type":"journal-article","created":{"date-parts":[[2026,6,7]],"date-time":"2026-06-07T18:57:38Z","timestamp":1780858658000},"page":"4119-4128","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The relationship between hematological indices of systemic inflammation and disease activity in patients with rheumatoid arthritis: a retrospective cross-sectional study"],"prefix":"10.1007","volume":"45","author":[{"given":"Zahra","family":"Nourmohammadi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meysam","family":"Olfatifar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Reza","family":"Ahmadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reyhaneh","family":"Motaghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimia","family":"Jazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2635-2656","authenticated-orcid":false,"given":"Maryam","family":"Masoumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra Haji","family":"khodadadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahdiye","family":"Ehsani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arefeh","family":"Khodaee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rasoul","family":"shajari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,7]]},"reference":[{"issue":"11","key":"8198_CR1","doi-asserted-by":"publisher","DOI":"10.3390\/cells10112857","volume":"10","author":"A-F Radu","year":"2021","unstructured":"Radu A-F, Bungau SG (2021) Management of rheumatoid arthritis: an overview. Cells 10(11):2857","journal-title":"Cells"},{"key":"8198_CR2","unstructured":"Epidemiology of, risk factors for, and possible causes of rheumatoid arthritis [Internet]. Uptodate. Feb 19, 2024. Available from: https:\/\/www.uptodate.com\/contents\/epidemiology-of-risk-factors-for-and-possible-causes-of-rheumatoid-arthritis"},{"key":"8198_CR3","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/s41413-018-0016-9","volume":"6","author":"Q Guo","year":"2018","unstructured":"Guo Q, Wang Y, Xu D, Nossent J, Pavlos NJ, Xu J (2018) Rheumatoid arthritis: pathological mechanisms and modern pharmacologic therapies. Bone Res 6:15","journal-title":"Bone Res"},{"issue":"6","key":"8198_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9062008","volume":"9","author":"J-W Kim","year":"2020","unstructured":"Kim J-W, Suh C-H (2020) Systemic manifestations and complications in patients with rheumatoid arthritis. J Clin Med 9(6):2008","journal-title":"J Clin Med"},{"key":"8198_CR5","doi-asserted-by":"publisher","DOI":"10.3390\/medicina59010117","author":"JY Choe","year":"2023","unstructured":"Choe JY, Lee CU, Kim SK (2023) Association between novel hematological indices and measures of disease activity in patients with rheumatoid arthritis. Medicina (Kaunas). https:\/\/doi.org\/10.3390\/medicina59010117","journal-title":"Medicina (Kaunas)"},{"issue":"2","key":"8198_CR6","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1136\/ard.51.2.177","volume":"51","author":"DM van der Heijde","year":"1992","unstructured":"van der Heijde DM, van\u2019t Hof MA, van Riel PL, van Leeuwen MA, van Rijswijk MH, van de Putte LB (1992) Validity of single variables and composite indices for measuring disease activity in rheumatoid arthritis. Ann Rheum Dis 51(2):177\u2013181","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"8198_CR7","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1093\/rheumatology\/31.8.519","volume":"31","author":"DM van der Heijde","year":"1992","unstructured":"van der Heijde DM, van Riel PL, van Leeuwen MA, van \u2019t Hof MA, van Rijswijk MH, van de Putte LB (1992) Prognostic factors for radiographic damage and physical disability in early rheumatoid arthritis. A prospective follow-up study of 147 patients. Br J Rheumatol 31(8):519\u2013525","journal-title":"Br J Rheumatol"},{"issue":"5 Suppl 101","key":"8198_CR8","first-page":"S40","volume":"34","author":"P Van Riel","year":"2016","unstructured":"Van Riel P, Renskers L (2016) The disease activity score (DAS) and the disease activity score using 28 joint counts (DAS28) in the management of rheumatoid arthritis. Clin Exp Rheumatol 34(5 Suppl 101):S40\u2013S44","journal-title":"Clin Exp Rheumatol"},{"issue":"S1","key":"8198_CR9","first-page":"18","volume":"27","author":"S Kumar Gothwal","year":"2021","unstructured":"Kumar Gothwal S, Singh VB, Shrivastava M, Banseria R, Goyal K, Singh S et al (2021) Complete Blood-count-based Inflammatory Score (CBCS) of COVID-19 patients at tertiary care center. Altern Ther Health Med 27(S1):18\u201324","journal-title":"Altern Ther Health Med"},{"issue":"1","key":"8198_CR10","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-019-6466-7","volume":"20","author":"J-X Lin","year":"2020","unstructured":"Lin J-X, Lin J-P, Xie J-W, Wang J-b, Lu J, Chen Q-Y et al (2020) Complete blood count-based inflammatory score (CBCS) is a novel prognostic marker for gastric cancer patients after curative resection. BMC Cancer 20(1):11","journal-title":"BMC Cancer"},{"issue":"18","key":"8198_CR11","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241814378","volume":"24","author":"B-S Tudurachi","year":"2023","unstructured":"Tudurachi B-S, Anghel L, Tudurachi A, Sasc\u0103u RA, St\u0103tescu C (2023) Assessment of inflammatory hematological ratios (NLR, PLR, MLR, LMR and monocyte\/HDL\u2013cholesterol ratio) in acute myocardial infarction and particularities in young patients. Int J Mol Sci 24(18):14378","journal-title":"Int J Mol Sci"},{"issue":"3\u20134","key":"8198_CR12","first-page":"269","volume":"61","author":"H Fu","year":"2015","unstructured":"Fu H, Qin B, Hu Z, Ma N, Yang M, Wei T et al (2015) Neutrophil-and platelet-to-lymphocyte ratios are correlated with disease activity in rheumatoid arthritis. Clin Lab 61(3\u20134):269\u2013273","journal-title":"Clin Lab"},{"issue":"5","key":"8198_CR13","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1007\/s00296-019-04276-x","volume":"39","author":"H-N Lee","year":"2019","unstructured":"Lee H-N, Kim Y-K, Kim G-T, Ahn E, So MW, Sohn DH et al (2019) Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratio as predictors of 12-week treatment response and drug persistence of anti-tumor necrosis factor-\u03b1 agents in patients with rheumatoid arthritis: a retrospective chart review analysis. Rheumatol Int 39(5):859\u2013868","journal-title":"Rheumatol Int"},{"issue":"12","key":"8198_CR14","doi-asserted-by":"publisher","first-page":"2122","DOI":"10.1111\/1756-185X.13400","volume":"21","author":"G Sargin","year":"2018","unstructured":"Sargin G, Senturk T, Yavasoglu I, Kose R (2018) Relationship between neutrophil-lymphocyte, platelet-lymphocyte ratio and disease activity in rheumatoid arthritis treated with rituximab. Int J Rheum Dis 21(12):2122\u20132127","journal-title":"Int J Rheum Dis"},{"issue":"1","key":"8198_CR15","doi-asserted-by":"publisher","first-page":"39","DOI":"10.5606\/ArchRheumatol.2017.6033","volume":"32","author":"M Maden","year":"2017","unstructured":"Maden M, Pamuk GE, Pamuk \u00d6N (2017) Development of atherosclerotic cardiovascular mortality in gouty arthritis and rheumatoid arthritis patients: are they associated with mean platelet volume and neutrophil-lymphocyte ratio? A comparative study. Arch Rheumatol 32(1):39","journal-title":"Arch Rheumatol"},{"issue":"5","key":"8198_CR16","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines8050125","volume":"8","author":"RR Mititelu","year":"2020","unstructured":"Mititelu RR, P\u0103dureanu R, B\u0103c\u0103noiu M, P\u0103dureanu V, Docea AO, Calina D et al (2020) Inflammatory and oxidative stress markers\u2014mirror tools in rheumatoid arthritis. Biomedicines 8(5):125","journal-title":"Biomedicines"},{"issue":"3","key":"8198_CR17","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1007\/s40123-022-00511-0","volume":"11","author":"D Kazantzis","year":"2022","unstructured":"Kazantzis D, Machairoudia G, Kroupis C, Theodossiadis G, Theodossiadis P, Chatziralli I (2022) Complete blood count-derived inflammation indices and retinal vein occlusion: a case\u2013control study. Ophthalmol Ther 11(3):1241\u20131249","journal-title":"Ophthalmol Ther"},{"issue":"8","key":"8198_CR18","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1097\/MCA.0000000000001037","volume":"32","author":"Y Liu","year":"2021","unstructured":"Liu Y, Ye T, Chen L, Jin T, Sheng Y, Wu G et al (2021) Systemic immune-inflammation index predicts the severity of coronary stenosis in patients with coronary heart disease. Coron Artery Dis 32(8):715\u2013720","journal-title":"Coron Artery Dis"},{"issue":"2","key":"8198_CR19","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1007\/s10067-020-05266-2","volume":"40","author":"J-W Kim","year":"2021","unstructured":"Kim J-W, Jung J-Y, Suh C-H, Kim H-A (2021) Systemic immune-inflammation index combined with ferritin can serve as a reliable assessment score for adult-onset Still\u2019s disease. Clin Rheumatol 40(2):661\u2013668","journal-title":"Clin Rheumatol"},{"issue":"7","key":"8198_CR20","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1111\/nep.13491","volume":"24","author":"Y Kim","year":"2019","unstructured":"Kim Y, Choi H, Jung SM, Song JJ, Park Y-B, Lee S-W (2019) Systemic immune-inflammation index could estimate the cross-sectional high activity and the poor outcomes in immunosuppressive drug-na\u00efve patients with antineutrophil cytoplasmic antibody-associated vasculitis. Nephrology Carlton Vic 24(7):711\u2013717","journal-title":"Nephrology Carlton Vic"},{"issue":"4","key":"8198_CR21","first-page":"553","volume":"47","author":"S Satis","year":"2021","unstructured":"Satis S (2021) New inflammatory marker associated with disease activity in rheumatoid arthritis: the systemic immune-inflammation index. Curr Health Sci J 47(4):553","journal-title":"Curr Health Sci J"},{"issue":"9","key":"8198_CR22","doi-asserted-by":"publisher","DOI":"10.1002\/jcla.23964","volume":"35","author":"J Wu","year":"2021","unstructured":"Wu J, Yan L, Chai K (2021) Systemic immune-inflammation index is associated with disease activity in patients with ankylosing spondylitis. J Clin Lab Anal 35(9):e23964","journal-title":"J Clin Lab Anal"},{"issue":"Suppl 6","key":"8198_CR23","doi-asserted-by":"publisher","first-page":"vi5","DOI":"10.1093\/rheumatology\/kes279","volume":"51","author":"J Kay","year":"2012","unstructured":"Kay J, Upchurch KS (2012) ACR\/EULAR 2010 rheumatoid arthritis classification criteria. Rheumatology (Oxford) 51(Suppl 6):vi5-9","journal-title":"Rheumatology (Oxford)"},{"issue":"11","key":"8198_CR24","first-page":"6524","volume":"15","author":"J Bai","year":"2023","unstructured":"Bai J, Tian Y, Wang F, Dang J, Wang H (2023) Role of systemic immune-inflammation index (SII) in assessing clinical efficacy of TNF-\u03b1 inhibitors for rheumatoid arthritis. Am J Transl Res 15(11):6524\u20136533","journal-title":"Am J Transl Res"},{"issue":"Suppl 11","key":"8198_CR25","first-page":"S14","volume":"63","author":"JK Anderson","year":"2011","unstructured":"Anderson JK, Zimmerman L, Caplan L, Michaud K (2011) Measures of rheumatoid arthritis disease activity: patient (PtGA) and provider (PrGA) global assessment of disease activity, disease activity score (DAS) and disease activity score with 28-joint counts (DAS28), simplified disease activity index (SDAI), clinical disease activity index (CDAI), patient activity score (PAS) and patient activity score-II (PASII), routine assessment of patient index data (RAPID), rheumatoid arthritis disease activity index (RADAI) and rheumatoid arthritis disease activity index-5 (RADAI-5), chronic arthritis systemic index (CASI), patient-based disease activity score with ESR (PDAS1) and patient-based disease activity score without ESR (PDAS2), and mean overall index for rheumatoid arthritis (MOI-RA). Arthritis Care Res (Hoboken) 63(Suppl 11):S14-36","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"3","key":"8198_CR26","first-page":"183","volume":"39","author":"A Dervisevic","year":"2024","unstructured":"Dervisevic A, Fajkic A, Jahic E, Dervisevic L, Ajanovic Z, Ademovic E et al (2024) Systemic immune-inflammation index in evaluation of inflammation in rheumatoid arthritis patients. Medeni Med J 39(3):183\u201391","journal-title":"Medeni Med J"},{"issue":"6","key":"8198_CR27","doi-asserted-by":"publisher","first-page":"439","DOI":"10.5114\/reum\/196066","volume":"62","author":"\u0130 Okutan","year":"2024","unstructured":"Okutan \u0130, Aci R, Keskin \u00c2, Bilgin M, K\u0131z\u0131let H (2024) New inflammatory markers associated with disease activity in rheumatoid arthritis: pan-immune-inflammation value, systemic immune-inflammation index, and systemic inflammation response index. Reumatologia 62(6):439\u2013446","journal-title":"Reumatologia"},{"issue":"2","key":"8198_CR28","doi-asserted-by":"publisher","DOI":"10.1111\/eci.13877","volume":"53","author":"A Zinellu","year":"2023","unstructured":"Zinellu A, Mangoni AA (2023) Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratio and disease activity in rheumatoid arthritis: a systematic review and meta-analysis. Eur J Clin Invest 53(2):e13877","journal-title":"Eur J Clin Invest"},{"issue":"Suppl 3","key":"8198_CR29","doi-asserted-by":"publisher","first-page":"S265","DOI":"10.1186\/ar578","volume":"4","author":"AJ Silman","year":"2002","unstructured":"Silman AJ, Pearson JE (2002) Epidemiology and genetics of rheumatoid arthritis. Arthritis Res 4(Suppl 3):S265\u2013S272","journal-title":"Arthritis Res"},{"issue":"10055","key":"8198_CR30","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1016\/S0140-6736(16)30173-8","volume":"388","author":"JS Smolen","year":"2016","unstructured":"Smolen JS, Aletaha D, McInnes IB (2016) Rheumatoid arthritis. Lancet 388(10055):2023\u20132038","journal-title":"Lancet"},{"issue":"10086","key":"8198_CR31","doi-asserted-by":"publisher","first-page":"2328","DOI":"10.1016\/S0140-6736(17)31472-1","volume":"389","author":"IB McInnes","year":"2017","unstructured":"McInnes IB, Schett G (2017) Pathogenetic insights from the treatment of rheumatoid arthritis. Lancet 389(10086):2328\u20132337","journal-title":"Lancet"},{"key":"8198_CR32","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.coph.2018.03.006","volume":"40","author":"Y Tanaka","year":"2018","unstructured":"Tanaka Y, Ohira T (2018) Mechanisms and therapeutic targets for bone damage in rheumatoid arthritis, in particular the RANK-RANKL system. Curr Opin Pharmacol 40:110\u2013119","journal-title":"Curr Opin Pharmacol"},{"issue":"1","key":"8198_CR33","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1007\/s00774-018-0965-5","volume":"37","author":"Y Tanaka","year":"2019","unstructured":"Tanaka Y (2019) Clinical immunity in bone and joints. J Bone Miner Metab 37(1):2\u20138","journal-title":"J Bone Miner Metab"},{"issue":"1","key":"8198_CR34","doi-asserted-by":"publisher","DOI":"10.1186\/s41232-020-00133-8","volume":"40","author":"Y Tanaka","year":"2020","unstructured":"Tanaka Y (2020) Rheumatoid Arthritis. Inflamm Regen 40(1):20","journal-title":"Inflamm Regen"},{"key":"8198_CR35","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.916453","volume":"9","author":"H Ghobadi","year":"2022","unstructured":"Ghobadi H, Mohammadshahi J, Javaheri N, Fouladi N, Mirzazadeh Y, Aslani MR (2022) Role of leukocytes and systemic inflammation indexes (NLR, PLR, MLP, dNLR, NLPR, AISI, SIR-I, and SII) on admission predicts in-hospital mortality in non-elderly and elderly COVID-19 patients. Front Med (Lausanne) 9:916453","journal-title":"Front Med (Lausanne)"},{"issue":"14","key":"8198_CR36","doi-asserted-by":"publisher","first-page":"2158","DOI":"10.1002\/cncr.30057","volume":"122","author":"Q Qi","year":"2016","unstructured":"Qi Q, Zhuang L, Shen Y, Geng Y, Yu S, Chen H et al (2016) A novel systemic inflammation response index (SIRI) for predicting the survival of patients with Pancreatic Cancer after chemotherapy. Cancer 122(14):2158\u20132167","journal-title":"Cancer"},{"key":"8198_CR37","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.00766","volume":"10","author":"B Chao","year":"2020","unstructured":"Chao B, Ju X, Zhang L, Xu X, Zhao Y (2020) A novel prognostic marker systemic inflammation response index (SIRI) for operable cervical cancer patients. Front Oncol 10:766","journal-title":"Front Oncol"},{"issue":"1","key":"8198_CR38","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1080\/0886022X.2022.2100262","volume":"44","author":"J Li","year":"2022","unstructured":"Li J, Li Y, Zou Y, Chen Y, He L, Wang Y et al (2022) Use of the systemic inflammation response index (SIRI) as a novel prognostic marker for patients on peritoneal dialysis. Ren Fail 44(1):1227\u20131235","journal-title":"Ren Fail"},{"issue":"3","key":"8198_CR39","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1515\/enr-2016-0017","volume":"50","author":"H Keskin","year":"2016","unstructured":"Keskin H, Kaya Y, Cadirci K, Kucur C, Ziypak E, Simsek E et al (2016) Elevated neutrophil-lymphocyte ratio in patients with euthyroid chronic autoimmune thyreotidis. Endocr Regul 50(3):148\u2013153","journal-title":"Endocr Regul"},{"issue":"10","key":"8198_CR40","volume":"11","author":"A Zeb","year":"2019","unstructured":"Zeb A, Khurshid S, Bano S, Rasheed U, Zammurrad S, Khan MS et al (2019) The role of the neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio as markers of disease activity in ankylosing spondylitis. Cureus 11(10):e6025","journal-title":"Cureus"},{"issue":"21","key":"8198_CR41","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000006981","volume":"96","author":"Y Jiang","year":"2017","unstructured":"Jiang Y, Zang M, Li S (2017) Serum PLR and LMR in Beh\u00e7et\u2019s disease: can they show the disease activity? Medicine (Baltimore) 96(21):e6981","journal-title":"Medicine (Baltimore)"},{"key":"8198_CR42","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.intimp.2018.02.008","volume":"57","author":"Y Huang","year":"2018","unstructured":"Huang Y, Deng W, Zheng S, Feng F, Huang Z, Huang Q et al (2018) Relationship between monocytes to lymphocytes ratio and axial spondyloarthritis. Int Immunopharmacol 57:43\u201346","journal-title":"Int Immunopharmacol"},{"key":"8198_CR43","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.intimp.2018.08.022","volume":"64","author":"Y Huang","year":"2018","unstructured":"Huang Y, Liu A, Liang L, Jiang J, Luo H, Deng W et al (2018) Diagnostic value of blood parameters for community-acquired pneumonia. Int Immunopharmacol 64:10\u201315","journal-title":"Int Immunopharmacol"},{"issue":"34","key":"8198_CR44","doi-asserted-by":"publisher","first-page":"54564","DOI":"10.18632\/oncotarget.10515","volume":"7","author":"C Lolli","year":"2016","unstructured":"Lolli C, Basso U, Derosa L, Scarpi E, Sava T, Santoni M et al (2016) Systemic immune-inflammation index predicts the clinical outcome in patients with metastatic renal cell cancer treated with sunitinib. Oncotarget 7(34):54564\u201354571","journal-title":"Oncotarget"},{"key":"8198_CR45","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2016.00376","volume":"7","author":"C Lolli","year":"2016","unstructured":"Lolli C, Caffo O, Scarpi E, Aieta M, Conteduca V, Maines F et al (2016) Systemic immune-inflammation index predicts the clinical outcome in patients with mCRPC treated with abiraterone. Front Pharmacol 7:376","journal-title":"Front Pharmacol"},{"issue":"82","key":"8198_CR46","doi-asserted-by":"publisher","first-page":"35293","DOI":"10.18632\/oncotarget.24293","volume":"9","author":"C Li","year":"2018","unstructured":"Li C, Tian W, Zhao F, Li M, Ye Q, Wei Y et al (2018) Systemic immune-inflammation index, SII, for prognosis of elderly patients with newly diagnosed tumors. Oncotarget 9(82):35293\u201335299","journal-title":"Oncotarget"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-026-08198-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-026-08198-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-026-08198-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T05:08:33Z","timestamp":1783400913000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-026-08198-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,7]]},"references-count":46,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["8198"],"URL":"https:\/\/doi.org\/10.1007\/s10067-026-08198-5","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,7]]},"assertion":[{"value":"8 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 June 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"This study was reviewed and approved by Qom University of Medical Science (approval number IR.MUQ.REC.1402.126, dated 30 August 2023) conducted in accordance with the Declaration of Helsinki. All participants were informed of the study design, and written informed consent was obtained from all those who participated in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"During the preparation of this work, the authors used ChatGPT only to edit and refine the phrasing of sentences. The authors reviewed and edited all content as needed and take full responsibility for the final version of the manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Generative AI and AI-assisted technologies in the writing process"}},{"value":"None.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}